Close Menu
    Facebook X (Twitter) Instagram
    BusinessNews.phBusinessNews.ph
    Subscribe
    • Top Stories
    • Business
    • Events / Conventions
    • National
    • Technology
    BusinessNews.phBusinessNews.ph
    Home ยป Endpoints News Presents “Why Australia and Agilex Biolabs for your Next Clinical Trial” for Bio Europe 2020
    Medical

    Endpoints News Presents “Why Australia and Agilex Biolabs for your Next Clinical Trial” for Bio Europe 2020

    By Marie JonesOctober 27, 2020Updated:October 27, 2020
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has partnered with Endpoints News to produce an exceptional step-by-step webinar on how to run your trial in Australia, and why Agilex Biolabs is the leading biolabs partner.

    Watch here (no charge) https://tinyurl.com/yyzf6o44

    Agilex Biolabs is known internationally for its continued investment in the latest technology, and for attracting some of the leading scientists from Australia and around the world.

    The webinar was launched as part of Agilex Biolabs’ presence at Bio Europe. Click here to meet Agilex Biolabs at Bio Europe via the partneringone tool. https://informaconnect.com/bio-europe-virtual/

    Dr Kurt J. Sales, Agilex Biolabs Director, Immunoassay B.Sc (Med)(Hons), M.Sc, PhD, PGCM led with a presentation detailing the rapid trials process in Australia.

    He stressed the importance of talking to Agilex Biolabs early, even before selecting a CRO and other partners, due to the depth of advice the scientific team can offer Sponsors, and the time it can take to develop some assays.

    The webinar also featured leading clinical research specialist Jane Kelly who has 27 years in the industry. She is CEO of CMAX Clinical Research, a major Phase 1 Unit located near Agilex Biolabs.

    Kelly pointed to the significant advantages of having the biolabs close to the Phase 1 Unit in terms of sample transfer and data turnaround, and offering a seamless clinical experience for Sponsors.

    Agilex Biolabs, the only FDA-inspected lab of its type in the region, also features a rebate of up to 43.5% on clinical trial bioanalytical services spend as part of the Australian Government clinical trial attraction program.

    Agilex Biolabs’ world-class bioanalytical facilities have OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition.

    The company has recently expanded its labs by more than 30% to accommodate biotech demand from APAC and the USA. Watch the New Labs Walkthrough Video Here https://www.agilexbiolabs.com/new-labs-video

    Agilex Biolabs specialises in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments utilising LC-MS/MS, immunoassay (Mesoscale, Gurolab, Luminex) and flow cytometry (BD FACSymphony A3, 20 colour cell analyser).

    Agilex also offers pharmacodynamics services that include immunobiology services using the latest state-of-the-art technology to support immunology, cell biology and mode of action assays, including:
    – Immunophenotyping
    – Receptor occupancy
    – Cytokine release assays (whole blood or PBMC stimulation assays) and cytokine/biomarker profiling
    – PBMC assays and cellular mechanism of action assays (eg: ADCC)

    Agilex Biolabs has more than 90 staff including 65 dedicated laboratory staff, and annually support more than 80 clinical trials. This year they will analyse more than 60,000 samples for pharma/biotechs companies from US, Europe and APAC.

    Please Book a Briefing with us before you start your next clinical trial. https://calendly.com/agilexbiolabs/15min

    Australia: +61 8 8302 8777 | China: +86 21 8036 9483 | South Korea: +82 80 812 1255 | USA: +1 800 247 1909

    About Agilex Biolabs https://www.agilexbiolabs.com/

    Agilex Biolabs, Australia’s leading bioanalytical laboratory, has more than 20 years’ experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services.

    Agilex Biolabs has successfully supported hundreds of preclinical and clinical trials around the world where customers choose Australia for the streamlined regulatory process and access to the world’s most attractive R&D rebate of more than 40% on clinical trial work conducted in Australia.

    The company offers services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.

    Agilex Biolabs operates a fully quality-assured laboratory ensuring that, within the principles of GLP, assays are validated to the latest FDA/EMA guidance and study samples are assayed and reported to the sponsor’s desired format using WATSON LIMS. Laboratory certifications include OECD GLP and ISO/IEC17025.

    Media Contact:
    Media@AgilexBiolabs.com
    Kate Newton

    For the latest business and finance news in Asia - Business News Asia
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025

    June 9, 2025

    Traditional Chinese Medicine Consumption Shows Promising Outlook, with Neautus’s Market Leadership Becoming Increasingly Evident

    June 3, 2025

    First patient dosed in YK012 trial-the world’s first TCE therapy for primary membranous nephropathy

    May 29, 2025
    Latest News

    10 winners selected at 8th edition of Start-up Express

    June 12, 2025

    This Technology is Conquering the World: Neutrinovoltaics Redefining Global Infrastructure

    June 11, 2025

    HKTDC Design Gallery x STICKYLINE present: “Love HK” Exhibition

    June 11, 2025

    Blockpass partners with CryptoSwift to deliver global Travel Rule Compliance

    June 11, 2025

    U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London

    June 10, 2025

    UK MOD Signs Protector Support Contract with GA-ASI

    June 10, 2025

    New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises

    June 9, 2025

    SRKay Consulting Group Releases Research Report: ‘From Legal Frameworks to Successful Operations’–A Strategic Playbook for India Market Entry

    June 9, 2025

    Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025

    June 9, 2025

    Latest Firewall Vulnerability Reinforces Need for Post-Breach Privileged Access Controls – TACACS.net Offers a Critical Layer

    June 6, 2025

    TANAKA PRECIOUS METAL TECHNOLOGIES Receives 2025 Technology Award from Catalyst Manufacturers Association, Japan, for Development and Practical Application of Electrode Catalysts for PEM Water Electrolysis

    June 6, 2025

    Naoris Protocol Expands into the Nordics with Strategic Consulting Hub in Oslo

    June 5, 2025

    TF International Facilitates Hong Kong’s Successful Issuance of First Central Asian Sovereign Bond

    June 5, 2025

    LIMA’25 Wraps up with RM11 Billion in Deals and Record Global Participation

    June 4, 2025

    Global Communities Unite at centralwOrld as Thailand Steps Forward on Global LGBTQ+ Stage with Central Pattana’s Pride For All

    June 4, 2025
    BusinessNews.ph
    • Home
    • Business News Asia
    • Cebu Lifestyle Channel
    • Property News
    • Events News Asia.com
    • Contact Us
    • Cebu Business News
    © 2025 All Rights Reserved | BusinessNews.ph

    Type above and press Enter to search. Press Esc to cancel.